These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7744150)

  • 1. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group.
    Aso Y; Akaza H; Kotake T; Tsukamoto T; Imai K; Naito S
    Eur Urol; 1995; 27(2):104-9. PubMed ID: 7744150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer. BLP Study Group.
    Aso Y; Akazan H
    Urol Int; 1992; 49(3):125-9. PubMed ID: 1466089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer.
    Naito S; Koga H; Yamaguchi A; Fujimoto N; Hasui Y; Kuramoto H; Iguchi A; Kinukawa N;
    J Urol; 2008 Feb; 179(2):485-90. PubMed ID: 18076918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New strategy of bio-chemoprevention on recurrence of superficial bladder cancer based on a hypothesis of the mechanism of recurrence.
    Akaza H
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():253-6. PubMed ID: 9210905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
    Hinotsu S; Akaza H; Ohashi Y; Kotake T
    Cancer; 1999 Nov; 86(9):1818-26. PubMed ID: 10547556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
    Messing E; Kim KM; Sharkey F; Schultz M; Parnes H; Kim D; Saltzstein D; Wilding G
    J Urol; 2006 Aug; 176(2):500-4. PubMed ID: 16813878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on "Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?".
    Naito S
    Nat Clin Pract Urol; 2009 Mar; 6(3):E5. PubMed ID: 19265853
    [No Abstract]   [Full Text] [Related]  

  • 8. Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial.
    Alfthan O; Tarkkanen J; Gröhn P; Heinonen E; Pyrhönen S; Säilä K
    Eur Urol; 1983; 9(1):6-9. PubMed ID: 6337054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of adjunctive immunotherapy in superficial bladder cancer.
    Fujita K
    Cancer; 1987 Jun; 59(12):2027-30. PubMed ID: 3567865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic oral UFT therapy for superficial bladder cancer.
    Kubota Y; Hosaka M; Fukushima S; Kondo I
    Cancer; 1993 Mar; 71(5):1842-5. PubMed ID: 8448746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder III.
    Rajala P; Liukkonen T; Raitanen M; Rintala E; Kaasinen E; Helle M; Lukkarinen O
    J Urol; 1999 Apr; 161(4):1133-5; discussion 1135-6. PubMed ID: 10081854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study.
    Boccardo F; Cannata D; Rubagotti A; Guarneri D; Decensi A; Canobbio L; Curotto A; Martorana G; Pegoraro C; Selvaggi F
    J Clin Oncol; 1994 Jan; 12(1):7-13. PubMed ID: 8270987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic treatment of superficial bladder tumor.
    Lee C; Park MS
    Int J Urol; 1998 Nov; 5(6):511-20. PubMed ID: 9855117
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of treatment methods for the prophylaxis of recurrent superficial bladder tumors.
    Rodrigues Netto Júnior N; Lemos GC
    J Urol; 1983 Jan; 129(1):33-4. PubMed ID: 6402610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group.
    Newling DW; Robinson MR; Smith PH; Byar D; Lockwood R; Stevens I; De Pauw M; Sylvester R
    Eur Urol; 1995; 27(2):110-6. PubMed ID: 7744151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study.
    Denzinger S; Wieland WF; Otto W; Filbeck T; Knuechel R; Burger M
    BJU Int; 2008 Mar; 101(5):566-9. PubMed ID: 17986289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
    Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
    Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled study of intravesical epirubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder. Finnish Multicentre Study Group.
    Raitanen MP; Lukkarinen O
    Br J Urol; 1995 Dec; 76(6):697-701. PubMed ID: 8535711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of superficial transitional cell bladder carcinoma. Long-term results of trial comparing transurethral resection alone and adjuvant chemotherapy with Doxorubicin].
    Milonas D; Mickevicius J; Mickevicius R; Motiejūnas A; Sukys D; Gudinaviciene I
    Medicina (Kaunas); 2002; 38 Suppl 1():79-83. PubMed ID: 12556642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very Long-Term Treatment with a
    Mutoh M; Yoshimura K; Fujii G; Nakamura T; Takeshita T; Wakabayashi K; Sakai T; Ishikawa H
    Nutrients; 2020 May; 12(6):. PubMed ID: 32485893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.